 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Laboratories & Research > Regeneration Technologies, Inc.
 |
Regeneration Technologies, Inc. |
 |
 |
 |
PROFILE |
 |
It's not the giving, it's the receiving. Regeneration Technologies develops allografts (tissues harvested from cadavers and processed for use in living patients) for various surgical and therapeutic procedures. Using its BioCleanse aseptic process, the company primarily develops bone allografts for spinal column repair and processes tissues for other orthopedic procedures, as well as for urological and cardiovascular applications. The University of Florida Tissue Bank, whose allograft operations were used to form Regeneration Technologies, is among the firm's biggest tissue suppliers. The company has distribution agreements with Medtronic Sofamor Danek, Exactech, and C. R. Bard.
COMPETITION |
 |
Interpore International, Inc. (BONZ)
Osteotech, Inc. (OSTE)
Tutogen Medical Inc. (TTG)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 122.50
1-Yr. Sales Growth: 271.2%
Employees: 345
Revenue per employee: $355,072.46
KEY PEOPLE |
 |
James M. Grooms
CEO
Richard R. Allen
CFO
CONTACT INFO |
 |
1 Innovation Dr.
Alachua, FL 32615
US
Phone: 904-418-8888
Fax: 904-418-0342
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |